InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-14.7%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by DAMELIO FRANK A, Director. Director active across 4 companies, notably Zoetis Inc.. In total, 11 disclosures have been recorded. Split: 2 buys · 0 sell. Total volume traded: €856k. History available since 23 February 2022. The latest transaction was filed on 13 May 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations11 total
6,650 shares@ US$75.390.0014% mcap50.0% of flowCommon StockSEC:0001628280-26-034643:0
Ideal exit: 7 Feb 2027 (T+270)
6,650 shares@ US$75.390.0014% mcap50.0% of flowCommon StockSEC:0001628280-26-034643
Ideal exit: 7 Feb 2027 (T+270)
14,322.993 shares@ US$16.12100.0% of flowCommon StockSEC:0001062993-25-007104:0
12,635 sharesCommon StockSEC:0000950170-24-137717:0
4,663 shares0Common StockSEC:0001596783-24-000107:0
17,389.938 shares0Common StockSEC:0001062993-24-008359:0
6,993 shares0Common StockSEC:0001596783-23-000151:0
979 shares0Common StockSEC:0001596783-23-000113:0
3,444 shares0Common StockSEC:0001062993-23-008947:0
127,160 shares@ US$25.600.0020% mcap43.9% of flowCommon StockSEC:0001225208-22-003723:0
153,789 shares@ US$27.340.0026% mcap56.1% of flowCommon StockSEC:0001225208-22-003466:0
11 of 11 declarations
About DAMELIO FRANK A
Frank A. Damelio is a Director and Executive Vice President at Zoetis Inc. and Pfizer Inc. In these roles, he contributes to the strategic direction of the companies, which specialize in animal and pharmaceutical health. Mr. Damelio brings his expertise in governance and operations management to the board, actively participating in discussions on policies and company objectives.
